Results 21 to 30 of about 20,377 (198)

The importance of tests applied to evaluate the effectiveness of antiplatelet therapy in patients with recurrent coronary stent thrombosis [PDF]

open access: yes, 2009
Background. Stent thrombosis is potentially lethal complication with huge economic burden. The role of insufficient response to antiplatelet therapy is still unclear reason for its occurrence. Case report.
Cikota Bojana   +10 more
core   +1 more source

Use of anticoagulation at the time of discharge in patients with heart failure and atrial fibrillation [PDF]

open access: yes, 2003
[Resumen] Introducción y objetivos. Evaluar el grado de cumplimiento de las guías sobre uso de anticoagulación crónica en pacientes con insuficiencia cardíaca y fibrilación auricular. Pacientes y método.
Castro-Beiras, Alfonso   +4 more
core   +2 more sources

¿Qué hacer con los fármacos antiagregantes y anticoagulantes en la cirugía oftalmológica?

open access: yesRevista Electrónica de AnestesiaR, 2013
La mayoría de los pacientes programados para cirugía oftálmica suelen ser ancianos tratados regularmente con antiagregantes o anticoagulantes. Más del 28% de ellos toman aspirina, un 2% clopidogrel y alrededor del 5% anticoagulantes.
Anna Abad Torrent
doaj   +1 more source

Intoxicación aguda por ácido acetil salicílico. Parte 1: farmacología y fisiopatología

open access: yesRevista Clínica de la Escuela de Medicina UCR-HSJD, 2016
El ácido acetil salicílicoes el analgésico, antipirético y antiinflamatorio de mayor uso en el mundo. La intoxicación aguda con salicilatos es entonces un cuadro frecuente, no obstante, a menudoel paciente no es adecuadamente reconocido o manejado. Esta
Rolf Chaverri Jara   +2 more
doaj   +1 more source

Aspirin and blood pressure: Effects when used alone or in combination with antihypertensive drugs

open access: yesRevista Portuguesa de Cardiologia, 2017
Arterial hypertension is a major risk factor for cardiovascular and renal events. Lowering blood pressure is thus an important strategy for reducing morbidity and mortality.
Ana Catarina Costa   +3 more
doaj   +1 more source

El final de la aspirina en la prevención primaria de las enfermedades cardiovasculares

open access: yesRevista Cubana de Medicina, 2020
RESUMEN Introducción: En la actualidad la aspirina es la droga de mayor uso a nivel internacional. Durante el año 2018, al menos parcialmente, se cuestionó la proporción riesgo/beneficio de la aspirina en la prevención primaria.
Alfredo Arredondo Bruce
doaj  

Cost–benefit analysis of first‐trimester pre‐eclampsia screening: comparison of multivariable Gaussian algorithm with and without placental growth factor

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 2, Page 162-167, February 2026.
ABSTRACT Objective Pre‐eclampsia (PE) is a leading cause of maternal and neonatal morbidity and mortality worldwide. Early identification of high‐risk pregnancies in the first trimester allows preventive treatment with low‐dose aspirin. This study aimed to evaluate whether multivariable Gaussian algorithm‐based PE screening strategies, with and without
E. Bonacina   +10 more
wiley   +1 more source

O Papel da Aspirina na Prevenção da Pré-Eclâmpsia: Estado da Arte

open access: yesActa Médica Portuguesa, 2015
Introdução: O papel do ácido acetilsalicílico (AAS ou aspirina) na prevenção das complicações associadas à pré-eclâmpsia tem sido objeto de estudos e de controvérsias ao longo de 30 anos.
Ana Campos
doaj   +1 more source

Effect of aspirin on maternal hemodynamics in Chinese women at high risk for preterm pre‐eclampsia: longitudinal study

open access: yesUltrasound in Obstetrics &Gynecology, Volume 66, Issue 5, Page 621-630, November 2025.
ABSTRACT Objectives To compare the maternal hemodynamics of Chinese women at low and at high risk for preterm pre‐eclampsia (PE) and assess the differences in hemodynamic parameters between high‐risk women with or without prophylactic aspirin. Methods This was a prospective longitudinal case–control study of 857 Chinese women with a singleton pregnancy
X. Wang   +11 more
wiley   +1 more source

Mieloma Múltiplo e distúrbios da hemostasia Hemostatic abnormalities in Multiple Myeloma

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2007
O mieloma múltiplo (MM) é o tumor de células plasmocitárias que corresponde a aproximadamente 10% das neoplasias hematológicas. Durante o seu curso clínico, relata-se que 15-30% dos pacientes podem apresentar manifestações hemorrágicas, decorrentes de ...
Elbio A. D'Amico, Paula R. Villaça
doaj   +1 more source

Home - About - Disclaimer - Privacy